Old Web
English
Sign In
Acemap
>
Paper
>
HER2-D16 oncogenic driver mutation confers osimertinib resistance in EGFR mutation-positive non-small cell lung cancer
HER2-D16 oncogenic driver mutation confers osimertinib resistance in EGFR mutation-positive non-small cell lung cancer
2020
Toshimitsu Yamaoka
Junji Tsurutani
Hironori Sagara
Tohru Ohmori
Keywords:
Cancer research
Lung cancer
Mutation
non small cell
Osimertinib
Biology
egfr mutation
Correction
Source
Cite
Save
Machine Reading By IdeaReader
34
References
2
Citations
NaN
KQI
[]